1 Hyperkalemia Treatment Market Overview 1.1 Product Overview and Scope of Hyperkalemia Treatment 1.2 Hyperkalemia Treatment Segment by Type 1.2.1 Global Hyperkalemia Treatment Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Patiromer 1.2.3 Sodium Zirconium Cyclosilicate 1.3 Hyperkalemia Treatment Segment by Distribution Channel 1.3.1 Global Hyperkalemia Treatment Sales Comparison by Distribution Channel: (2022-2028) 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.4 Global Hyperkalemia Treatment Market Size Estimates and Forecasts 1.4.1 Global Hyperkalemia Treatment Revenue 2017-2028 1.4.2 Global Hyperkalemia Treatment Sales 2017-2028 1.4.3 Hyperkalemia Treatment Market Size by Region: 2017 Versus 2021 Versus 2028 2 Hyperkalemia Treatment Market Competition by Manufacturers 2.1 Global Hyperkalemia Treatment Sales Market Share by Manufacturers (2017-2022) 2.2 Global Hyperkalemia Treatment Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Hyperkalemia Treatment Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Hyperkalemia Treatment Manufacturing Sites, Area Served, Product Type 2.5 Hyperkalemia Treatment Market Competitive Situation and Trends 2.5.1 Hyperkalemia Treatment Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Hyperkalemia Treatment Players Market Share by Revenue 2.5.3 Global Hyperkalemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Hyperkalemia Treatment Retrospective Market Scenario by Region 3.1 Global Hyperkalemia Treatment Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Hyperkalemia Treatment Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Hyperkalemia Treatment Market Facts & Figures by Country 3.3.1 North America Hyperkalemia Treatment Sales by Country 3.3.2 North America Hyperkalemia Treatment Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Hyperkalemia Treatment Market Facts & Figures by Country 3.4.1 Europe Hyperkalemia Treatment Sales by Country 3.4.2 Europe Hyperkalemia Treatment Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Hyperkalemia Treatment Market Facts & Figures by Region 3.5.1 Asia Pacific Hyperkalemia Treatment Sales by Region 3.5.2 Asia Pacific Hyperkalemia Treatment Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Chinese Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Hyperkalemia Treatment Market Facts & Figures by Country 3.6.1 Latin America Hyperkalemia Treatment Sales by Country 3.6.2 Latin America Hyperkalemia Treatment Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Hyperkalemia Treatment Market Facts & Figures by Country 3.7.1 Middle East and Africa Hyperkalemia Treatment Sales by Country 3.7.2 Middle East and Africa Hyperkalemia Treatment Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Hyperkalemia Treatment Historic Market Analysis by Type 4.1 Global Hyperkalemia Treatment Sales Market Share by Type (2017-2022) 4.2 Global Hyperkalemia Treatment Revenue Market Share by Type (2017-2022) 4.3 Global Hyperkalemia Treatment Price by Type (2017-2022) 5 Global Hyperkalemia Treatment Historic Market Analysis by Distribution Channel 5.1 Global Hyperkalemia Treatment Sales Market Share by Distribution Channel (2017-2022) 5.2 Global Hyperkalemia Treatment Revenue Market Share by Distribution Channel (2017-2022) 5.3 Global Hyperkalemia Treatment Price by Distribution Channel (2017-2022) 6 Key Companies Profiled 6.1 Vifor Pharma 6.1.1 Vifor Pharma Corporation Information 6.1.2 Vifor Pharma Description and Business Overview 6.1.3 Vifor Pharma Hyperkalemia Treatment Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Vifor Pharma Hyperkalemia Treatment Product Portfolio 6.1.5 Vifor Pharma Recent Developments/Updates 6.2 Astrazeneca 6.2.1 Astrazeneca Corporation Information 6.2.2 Astrazeneca Description and Business Overview 6.2.3 Astrazeneca Hyperkalemia Treatment Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Astrazeneca Hyperkalemia Treatment Product Portfolio 6.2.5 Astrazeneca Recent Developments/Updates 6.3 Sanofi 6.3.1 Sanofi Corporation Information 6.3.2 Sanofi Description and Business Overview 6.3.3 Sanofi Hyperkalemia Treatment Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Sanofi Hyperkalemia Treatment Product Portfolio 6.3.5 Sanofi Recent Developments/Updates 6.4 CMP Pharma 6.4.1 CMP Pharma Corporation Information 6.4.2 CMP Pharma Description and Business Overview 6.4.3 CMP Pharma Hyperkalemia Treatment Sales, Revenue and Gross Margin (2017-2022) 6.4.4 CMP Pharma Hyperkalemia Treatment Product Portfolio 6.4.5 CMP Pharma Recent Developments/Updates 6.5 Belcher Pharmaceuticals 6.5.1 Belcher Pharmaceuticals Corporation Information 6.5.2 Belcher Pharmaceuticals Description and Business Overview 6.5.3 Belcher Pharmaceuticals Hyperkalemia Treatment Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Belcher Pharmaceuticals Hyperkalemia Treatment Product Portfolio 6.5.5 Belcher Pharmaceuticals Recent Developments/Updates 7 Hyperkalemia Treatment Manufacturing Cost Analysis 7.1 Hyperkalemia Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Hyperkalemia Treatment 7.4 Hyperkalemia Treatment Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Hyperkalemia Treatment Distributors List 8.3 Hyperkalemia Treatment Customers 9 Hyperkalemia Treatment Market Dynamics 9.1 Hyperkalemia Treatment Industry Trends 9.2 Hyperkalemia Treatment Market Drivers 9.3 Hyperkalemia Treatment Market Challenges 9.4 Hyperkalemia Treatment Market Restraints 10 Global Market Forecast 10.1 Hyperkalemia Treatment Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Hyperkalemia Treatment by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Hyperkalemia Treatment by Type (2023-2028) 10.2 Hyperkalemia Treatment Market Estimates and Projections by Distribution Channel 10.2.1 Global Forecasted Sales of Hyperkalemia Treatment by Distribution Channel (2023-2028) 10.2.2 Global Forecasted Revenue of Hyperkalemia Treatment by Distribution Channel (2023-2028) 10.3 Hyperkalemia Treatment Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Hyperkalemia Treatment by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Hyperkalemia Treatment by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Hyperkalemia Treatment Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Hyperkalemia Treatment Sales Growth Rate Comparison by Distribution Channel (2022-2028) & (K Units) & (US$ Million) Table 3. Global Hyperkalemia Treatment Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Hyperkalemia Treatment Market Competitive Situation by Manufacturers in 2021 Table 5. Global Hyperkalemia Treatment Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Hyperkalemia Treatment Sales Market Share by Manufacturers (2017-2022) Table 7. Global Hyperkalemia Treatment Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Hyperkalemia Treatment Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Hyperkalemia Treatment Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Hyperkalemia Treatment Manufacturing Sites and Area Served Table 11. Manufacturers Hyperkalemia Treatment Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Hyperkalemia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperkalemia Treatment as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Hyperkalemia Treatment Sales by Region (2017-2022) & (K Units) Table 16. Global Hyperkalemia Treatment Sales Market Share by Region (2017-2022) Table 17. Global Hyperkalemia Treatment Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Hyperkalemia Treatment Revenue Market Share by Region (2017-2022) Table 19. North America Hyperkalemia Treatment Sales by Country (2017-2022) & (K Units) Table 20. North America Hyperkalemia Treatment Sales Market Share by Country (2017-2022) Table 21. North America Hyperkalemia Treatment Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Hyperkalemia Treatment Revenue Market Share by Country (2017-2022) Table 23. Europe Hyperkalemia Treatment Sales by Country (2017-2022) & (K Units) Table 24. Europe Hyperkalemia Treatment Sales Market Share by Country (2017-2022) Table 25. Europe Hyperkalemia Treatment Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Hyperkalemia Treatment Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Hyperkalemia Treatment Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Hyperkalemia Treatment Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Hyperkalemia Treatment Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Hyperkalemia Treatment Revenue Market Share by Region (2017-2022) Table 31. Latin America Hyperkalemia Treatment Sales by Country (2017-2022) & (K Units) Table 32. Latin America Hyperkalemia Treatment Sales Market Share by Country (2017-2022) Table 33. Latin America Hyperkalemia Treatment Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Hyperkalemia Treatment Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Hyperkalemia Treatment Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Hyperkalemia Treatment Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Hyperkalemia Treatment Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Hyperkalemia Treatment Revenue Market Share by Country (2017-2022) Table 39. Global Hyperkalemia Treatment Sales by Type (2017-2022) & (K Units) Table 40. Global Hyperkalemia Treatment Sales Market Share by Type (2017-2022) Table 41. Global Hyperkalemia Treatment Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Hyperkalemia Treatment Revenue Share by Type (2017-2022) Table 43. Global Hyperkalemia Treatment Price by Type (2017-2022) & (USD/Unit) Table 44. Global Hyperkalemia Treatment Sales (K Units) by Distribution Channel (2017-2022) Table 45. Global Hyperkalemia Treatment Sales Market Share by Distribution Channel (2017-2022) Table 46. Global Hyperkalemia Treatment Revenue by Distribution Channel (2017-2022) & (US$ Million) Table 47. Global Hyperkalemia Treatment Revenue Share by Distribution Channel (2017-2022) Table 48. Global Hyperkalemia Treatment Price by Distribution Channel (2017-2022) & (USD/Unit) Table 49. Vifor Pharma Corporation Information Table 50. Vifor Pharma Description and Business Overview Table 51. Vifor Pharma Hyperkalemia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Vifor Pharma Hyperkalemia Treatment Product Table 53. Vifor Pharma Recent Developments/Updates Table 54. Astrazeneca Corporation Information Table 55. Astrazeneca Description and Business Overview Table 56. Astrazeneca Hyperkalemia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Astrazeneca Hyperkalemia Treatment Product Table 58. Astrazeneca Recent Developments/Updates Table 59. Sanofi Corporation Information Table 60. Sanofi Description and Business Overview Table 61. Sanofi Hyperkalemia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Sanofi Hyperkalemia Treatment Product Table 63. Sanofi Recent Developments/Updates Table 64. CMP Pharma Corporation Information Table 65. CMP Pharma Description and Business Overview Table 66. CMP Pharma Hyperkalemia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. CMP Pharma Hyperkalemia Treatment Product Table 68. CMP Pharma Recent Developments/Updates Table 69. Belcher Pharmaceuticals Corporation Information Table 70. Belcher Pharmaceuticals Description and Business Overview Table 71. Belcher Pharmaceuticals Hyperkalemia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Belcher Pharmaceuticals Hyperkalemia Treatment Product Table 73. Belcher Pharmaceuticals Recent Developments/Updates Table 74. Production Base and Market Concentration Rate of Raw Material Table 75. Key Suppliers of Raw Materials Table 76. Hyperkalemia Treatment Distributors List Table 77. Hyperkalemia Treatment Customers List Table 78. Hyperkalemia Treatment Market Trends Table 79. Hyperkalemia Treatment Market Drivers Table 80. Hyperkalemia Treatment Market Challenges Table 81. Hyperkalemia Treatment Market Restraints Table 82. Global Hyperkalemia Treatment Sales Forecast by Type (2023-2028) & (K Units) Table 83. Global Hyperkalemia Treatment Sales Market Share Forecast by Type (2023-2028) Table 84. Global Hyperkalemia Treatment Revenue Forecast by Type (2023-2028) & (US$ Million) Table 85. Global Hyperkalemia Treatment Revenue Market Share Forecast by Type (2023-2028) Table 86. Global Hyperkalemia Treatment Sales Forecast by Distribution Channel (2023-2028) & (K Units) Table 87. Global Hyperkalemia Treatment Sales Market Share Forecast by Distribution Channel (2023-2028) Table 88. Global Hyperkalemia Treatment Revenue Forecast by Distribution Channel (2023-2028) & (US$ Million) Table 89. Global Hyperkalemia Treatment Revenue Market Share Forecast by Distribution Channel (2023-2028) Table 90. Global Hyperkalemia Treatment Sales Forecast by Region (2023-2028) & (K Units) Table 91. Global Hyperkalemia Treatment Sales Market Share Forecast by Region (2023-2028) Table 92. Global Hyperkalemia Treatment Revenue Forecast by Region (2023-2028) & (US$ Million) Table 93. Global Hyperkalemia Treatment Revenue Market Share Forecast by Region (2023-2028) Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Hyperkalemia Treatment Figure 2. Global Hyperkalemia Treatment Market Share by Type in 2021 & 2028 Figure 3. Patiromer Product Picture Figure 4. Sodium Zirconium Cyclosilicate Product Picture Figure 5. Global Hyperkalemia Treatment Market Share by Distribution Channel in 2021 & 2028 Figure 6. Hospital Pharmacy Figure 7. Retail Pharmacy Figure 8. Global Hyperkalemia Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 9. Global Hyperkalemia Treatment Market Size (2017-2028) & (US$ Million) Figure 10. Global Hyperkalemia Treatment Sales (2017-2028) & (K Units) Figure 11. Hyperkalemia Treatment Sales Share by Manufacturers in 2021 Figure 12. Global Hyperkalemia Treatment Revenue Share by Manufacturers in 2021 Figure 13. The Global 5 and 10 Largest Hyperkalemia Treatment Players: Market Share by Revenue in 2021 Figure 14. Hyperkalemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 15. Global Hyperkalemia Treatment Sales Market Share by Region (2017-2022) Figure 16. Global Hyperkalemia Treatment Sales Market Share by Region in 2021 Figure 17. Global Hyperkalemia Treatment Revenue Market Share by Region (2017-2022) Figure 18. Global Hyperkalemia Treatment Revenue Market Share by Region in 2021 Figure 19. United States Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 20. Canada Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Germany Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. France Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. U.K. Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Italy Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Russia Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. China Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Japan Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. South Korea Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. India Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Australia Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Chinese Taiwan Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Indonesia Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Thailand Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Malaysia Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Mexico Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Brazil Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Argentina Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Turkey Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Saudi Arabia Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. UAE Hyperkalemia Treatment Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Sales Market Share of Hyperkalemia Treatment by Type (2017-2022) Figure 42. Manufacturing Cost Structure of Hyperkalemia Treatment Figure 43. Manufacturing Process Analysis of Hyperkalemia Treatment Figure 44. Hyperkalemia Treatment Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Vifor Pharma Astrazeneca Sanofi CMP Pharma Belcher Pharmaceuticals